Evidence map›Paper›PMID 38983519›Full record

ArticleFrontiers in ophthalmology2022

The full range of ophthalmological clinical manifestations in systemic lupus erythematosus.

Nikita Kedia, Vincent Theillac, Manuel Paez-Escamilla, Chad Indermill, Denise S Gallagher, Raphaël Adam, Anne Lise Qu-Knafo, Fatima Amari, Caroline Bottin, Géraldine Chotard and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Nikita KediaDepartment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Vincent TheillacDepartment of Ophthalmology, Quinze-Vingts National Eye Hospital, Sorbonne-Universités-UPMC & DHU ViewMaintain, Paris, France.
Manuel Paez-EscamillaDepartment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Chad IndermillDepartment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Denise S GallagherDepartment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Raphaël AdamDepartment of Ophthalmology, Quinze-Vingts National Eye Hospital, Sorbonne-Universités-UPMC & DHU ViewMaintain, Paris, France.
Anne Lise Qu-KnafoOphthalmology Department, Avicenne Hospital, Bobigny, Paris, France.
Fatima AmariOphthalmology Department, Avicenne Hospital, Bobigny, Paris, France.
Caroline BottinDepartment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Géraldine ChotardDepartment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Violaine CaillauxOphthalmology Department, Lariboisière Hospital, Paris, France.
Maté StréhoOphthalmology Department, Centre Explore Vision, Paris & Rueil-Malmaison, Paris, France.
Neila SediraDepartment of Internal Medicine, Quinze-Vingts National Eye Hospital, Sorbonne-Universités-UPMC & DHU ViewMaintain, Paris, France.
Emmanuel HéronDepartment of Internal Medicine, Quinze-Vingts National Eye Hospital, Sorbonne-Universités-UPMC & DHU ViewMaintain, Paris, France.
Pierre-André BecherelDermatology and Clinical Immunology Department, Hôpital Privé d'Antony, Antony, France.
Bahram BodaghiOphthalmology Department, Pitié Salpêtrière Hospital, Sorbonne-Universités-UPMC & DHU ViewMaintain, Paris, France.
Sarah Mrejen-UretskiDepartment of Ophthalmology, Quinze-Vingts National Eye Hospital, Sorbonne-Universités-UPMC & DHU ViewMaintain, Paris, France.
Alain-José SahelDepartment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
David SaadounInternal Medicine department, Pitié Salpêtrière Hospital, Sorbonne-Universités-UPMC, Paris, France.
Marie-Hélène ErreraDepartment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To determine the full range of ophthalmological clinical manifestations in systemic lupus erythematosus (SLE) and to compare the systemic features associated with them. Methods: Files of 13 patients with ocular SLE ( Results: The following clinical manifestations were found: keratoconjunctivitis sicca ( Discussion: SLE activity in the ophthalmic system is characterized by its functional severity and the range of involvement can be categorized by anatomical involvement: presence of anterior uveitis, episcleritis, scleritis, periorbital edema, posterior uveitis with retinal vascular ischemia, or papillary edema. Not currently part of the diagnosis criteria of the SLE ACR given its rarity, the ocular localization of the pathology led to the diagnosis of SLE in three cases; thus, developing a greater understanding of ocular lupus may help in identifying and treating systemic manifestations of lupus earlier.

Indexed as

idiopathic intracranial hypertensionlupusLupus retinopathyocular lupusoptic neuritisposterior scleritisuveitisuveitis (MeSH)

Identifiers

PMID38983519
PMCPMC11182226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.